Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 28, 2012; 18(44): 6357-6375
Published online Nov 28, 2012. doi: 10.3748/wjg.v18.i44.6357
Published online Nov 28, 2012. doi: 10.3748/wjg.v18.i44.6357
Dose mg/kg per d | Side effects | Structure | Approval | |
Growth hormone | 0.1 | Fluid retention, joint pain, hyperglycemia | 191-amino acid protein | FDA |
EGF | NA1 | NA | 53-amino acid peptide | Not available commercially |
GLP-2 | 0.1 | Abdominal pain/obstructive symptoms | dpp-IV resistant 33-amino acid peptide | Phase III clinical trials available in Europe |
- Citation: Shaw D, Gohil K, Basson MD. Intestinal mucosal atrophy and adaptation. World J Gastroenterol 2012; 18(44): 6357-6375
- URL: https://www.wjgnet.com/1007-9327/full/v18/i44/6357.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i44.6357